Skip to main content

Table 4 Prediction of recurrence and progression occurring between month 12-24 after urine sampling

From: Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer

Test Result n Rate of tumor recurrence in % (between month 12-24) Hazard ratio p-value Rate of tumor progression in % (between month 12-24) Hazard ratio p-value
Cytology - 68 14.7 2.89 (1.1-8.3) .04 2.9 5.7 (1.1-43.4) .04
+ 27 33.3 14.8
FISH - 63 14.3 2.72 (1.0-7.8) .05 3.2 4.35 (0.8-32.8) .08
+ 32 31.3 12.5
uCyt+ - 60 13.3 2.9 (1.1-8.6) .03 3.3 3.7 (0.7-28.1 .12
+ 35 31.4 11.4
NMP22 - 45 11.1 3.1 (1.1-10.4 .03 6.7 1.11 (0.2-6.3) .89
+ 50 28.0 6.0
  1. FISH = Fluorescence in situ hybridization, uCyt + = Immunocytology, NMP22 = Nuclear matrix protein 22.